TriangleFOR PATIENTS · SOURCE READING
Intravesical immunotherapy
Source: Bladder Cancer Treatment, National Cancer Institute.
Source updated: September 12, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Immunotherapy
BCG (bacillus Calmette-Guérin), nadofaragene firadenovec-vncg, and nogapendekin alfa inbakicept-pmln are intravesical immunotherapy drugs used to treat bladder cancer. They are given in a solution that is placed directly into the bladder using a catheter (thin tube). Intravesical treatments flush the bladder with drugs that kill cancer cells that remain after surgery. This lowers the chance of the cancer coming back.
Source links and citations
Learn more about Immunotherapy to Treat Cancer and Immunotherapy Side Effects.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice